The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Upfront cash of $25 million and milestone payments totalling up to $150 million contingent upon Recordati achieving predefined annual commercial net sales levels; Supply-based revenues, including ...

Eli Lilly has announced its intention to acquire Verve Therapeutics, a biotechnology company specializing in gene-editing ...

Fintel reports that on June 23, 2025, Evercore ISI Group downgraded their outlook for COMPASS Pathways plc - Depositary ...

Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- -- Conference Call Today at 8:00 ...

Easyjet rises 6% to lead FTSE 100 higher, oil prices drop on unsteady ceasefire - Stock markets latest updates and business news on Monday ...

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II trial has recently been ...

HealthDay News — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives Lilly a potential new treatment for heart disease, The Wall ...

Novo Nordisk accuses the telehealth company of breaking a law related to drug compounding. Ettinger Returns to Hormel Foods as Interim CEO Jeffrey Ettinger is returning to Hormel Foods to serve as its ...